alpha-2-Macroglobulin (A2M) (N-Term) Peptid
Kurzübersicht für alpha-2-Macroglobulin (A2M) (N-Term) Peptid (ABIN8094466)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- A2M Peptide - N-terminal region
-
Sequenz
- PVPGHVTVSI CRKYSDASDC HGEDSQAFCE KFSGQLNSHG CFYQQVKTKV
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-A2M Antibody (ARP59224_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- alpha 2 Macroglobulin (A2M) (alpha-2-Macroglobulin (A2M))
-
Hintergrund
-
Background Information: Alpha-2-macroglobulin is a protease inhibitor and cytokine transporter. It inhibits many proteases, including trypsin, thrombin and collagenase. A2M is implicated in Alzheimer disease (AD) due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits.
Alternative Symbols: CPAMD5, DKFZp779B086, FWP007, S863-7, A2MD
-
Molekulargewicht
- 161kDa
-
Gen-ID
- 2
-
NCBI Accession
- NP_000005
-
UniProt
- P01023
Target
-